Light	light	O	O	O	O
chain	chain	O	O	O	O
proteinuria	proteinuria	O	DISEASE	OTHERS	I
and	and	O	O	O	O
cellular	cellular	O	O	O	O
mediated	mediated	O	O	O	O
immunity	immunity	O	O	O	O
in	in	O	O	O	O
rifampin	rifampin	CHEMICALS	O	OTHERS	I
treated	treated	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
tuberculosis	tuberculosis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Light	light	O	O	O	O
chain	chain	O	O	O	O
proteinuria	proteinuria	O	DISEASE	OTHERS	I
was	was	O	O	O	O
found	found	O	O	O	O
in	in	O	O	O	O
9	9	O	O	O	O
of	of	O	O	O	O
17	17	O	O	O	O
tuberculosis	tuberculosis	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
rifampin	rifampin	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Concomitant	concomitant	O	O	O	O
assay	assay	O	O	O	O
of	of	O	O	O	O
cellular	cellular	O	O	O	O
mediated	mediated	O	O	O	O
immunity	immunity	O	O	O	O
in	in	O	O	O	O
these	these	O	O	O	O
patients	patients	O	O	O	O
using	using	O	O	O	O
skin	skin	O	O	O	O
test	test	O	O	O	O
antigen	antigen	O	O	O	O
and	and	O	O	O	O
a	a	O	O	O	O
lymphokine	lymphokine	O	O	O	O
in	in	O	O	O	O
vitro	vitro	O	O	O	O
test	test	O	O	O	O
provided	provided	O	O	O	O
results	results	O	O	O	O
that	that	O	O	O	O
were	were	O	O	O	O
different	different	O	O	O	O
.	.	O	O	O	O

Response	response	O	O	O	O
to	to	O	O	O	O
Varidase	varidase	O	O	O	O
skin	skin	O	O	O	O
test	test	O	O	O	O
antigen	antigen	O	O	O	O
was	was	O	O	O	O
negative	negative	O	O	O	O
for	for	O	O	O	O
all	all	O	O	O	O
eight	eight	O	O	O	O
tuberculosis	tuberculosis	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
tested	tested	O	O	O	O
,	,	O	O	O	O
but	but	O	O	O	O
there	there	O	O	O	O
occurred	occurred	O	O	O	O
a	a	O	O	O	O
hyper-responsiveness	hyper-responsiveness	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
lymphocytes	lymphocytes	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
eight	eight	O	O	O	O
patients	patients	O	O	O	O
to	to	O	O	O	O
phytomitogen	phytomitogen	O	O	O	O
(	(	O	O	O	O
PHA-P	pha-p	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

as	as	O	O	O	O
well	well	O	O	O	O
as	as	O	O	O	O
of	of	O	O	O	O
those	those	O	O	O	O
of	of	O	O	O	O
seven	seven	O	O	O	O
other	other	O	O	O	O
tuberculous	tuberculous	O	O	OTHERS	I
patients	patients	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
last	last	O	O	O	O
finding	finding	O	O	O	O
may	may	O	O	O	O
be	be	O	O	O	O
related	related	O	O	O	O
to	to	O	O	O	O
time	time	O	O	O	O
of	of	O	O	O	O
testing	testing	O	O	O	O
and/or	and/or	O	O	O	O
endogenous	endogenous	O	O	O	O
serum	serum	O	O	O	O
binding	binding	O	O	O	O
of	of	O	O	O	O
rifampin	rifampin	CHEMICALS	O	OTHERS	I
which	which	O	O	O	O
could	could	O	O	O	O
have	have	O	O	O	O
inhibited	inhibited	O	O	O	O
mitogen	mitogen	O	O	O	O
activity	activity	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
lymphocyte	lymphocyte	O	O	O	O
.	.	O	O	O	O

